Home/Filings/4/0001415889-25-005367
4//SEC Filing

Rona Jeffrey A 4

Accession 0001415889-25-005367

CIK 0001636651other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:55 PM ET

Size

7.3 KB

Accession

0001415889-25-005367

Insider Transaction Report

Form 4
Period: 2025-02-20
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-02-20+262,500262,500 total
    Exercise: $0.57Exp: 2035-02-19Common Stock (262,500 underlying)
  • Award

    Common Stock

    2025-02-20+43,75071,875 total
Footnotes (3)
  • [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in three equal annual installments commencing on February 22, 2026, subject to the Reporting Person's continuous service through each such vesting date.
  • [F2]Each RSU represents a contingent right to receive one share of Common Stock.
  • [F3]The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2025, subject to the Reporting Person's continued services through each such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001311404

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:55 PM ET
Size
7.3 KB